Osaic Holdings
MREO

Osaic Holdings’s Mereo BioPharma MREO Stock Holding History

Osaic Holdings’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$495 Buy
1,500
+1,000
+200% +$429 ﹤0.01% 7441
2025
Q4 		$208 Sell
500
-5,177
-91% -$9.85K ﹤0.01% 7577
2025
Q3 		$9.71K Buy
5,677
+300
+6% +$553 ﹤0.01% 6379
2025
Q2 		$14.6K Buy
5,377
+2,314
+76% +$5.58K ﹤0.01% 5931
2025
Q1 		$6.89K Buy
3,063
+2,934
+2,274% +$8.3K ﹤0.01% 6000
2024
Q4 		$452 Buy
+129
New +$507 ﹤0.01% 7040
2021
Q1 		– Sell
-410
Closed -$1K – 6892
2020
Q4 		$1K Buy
+410
New +$1.03K ﹤0.01% 6237

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Osaic Holdings's MREO Position: Q1 2026 in Review

Osaic Holdings increased its Mereo BioPharma (MREO) stake by 200% in Q1 2026, buying an estimated $429 and bringing the position to 1,500 shares worth $495. The position accounts for ﹤0.01% of the portfolio, ranked #7441.

Osaic Holdings first reported a position in MREO in Q4 2020 and has held it in 7 quarters since. The position peaked at $14.6K in Q2 2025. 63 funds tracked by Wall St. Rank hold MREO as of Q1 2026.

  • Osaic Holdings held 1,500 shares of Mereo BioPharma worth $495 as of Q1 2026.
  • Osaic Holdings bought 1,000 Mereo BioPharma shares in Q1 2026, an estimated $429.
  • Mereo BioPharma made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7441 holding.
  • Osaic Holdings first reported a position in Mereo BioPharma in Q4 2020 and has held it in 7 quarters since.
  • Osaic Holdings's Mereo BioPharma position peaked at $14.6K in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.